Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 5, 2013, Pages 659-665

  Fruth, K ^a   Pogorzelski, B ^a   Schmidtmann, I ^b   Springer, J ^a   Fennan, N ^a   Fraessdorf, N ^a   Boessert, A ^a   Schaefer, D ^c   Gosepath, J ^a   Mann, W J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

aspirin desensitization; aspirin exacerbated respiratory disease; chronic rhinosinusitis; maintenance dose; nasal polyp relapse

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADULT; ARACHIDONIC ACID METABOLISM; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; CHRONIC SINUSITIS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DESENSITIZATION; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENDOSCOPIC SINUS SURGERY; ENDOSCOPY; FEMALE; FOLLOW UP; HUMAN; LOW DRUG DOSE; MALE; NASAL ENDOSCOPY; NOSE POLYP; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SCORING SYSTEM;

ADULT; ASPIRIN; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RECURRENCE; RESPIRATORY HYPERSENSITIVITY; TREATMENT OUTCOME;

EID: 84876683025     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12131     Document Type: Article

References (29)

1. Gosepath J, Schafer D, Mann WJ,. Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day. Laryngorhinootologie 2002; 81: 732-738. (Pubitemid 35350952)
2. Stevenson DD,. Aspirin sensitivity and desensitization for asthma and sinusitis. Curr Allergy Asthma Rep 2009; 9: 155-163.
3. Stevenson DD, Szczeklik A,. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 2006; 118: 773-786. (Pubitemid 44515109)
4. Kowalski ML, Makowska JS, Blanca M, Bavbek S, Bochenek G, Bousquet J, et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)-classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNA. Allergy 2011; 66: 818-829.
5. Cheong HS, Park SM, Kim MO, Park JS, Lee JY, Byun JY, et al. Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics. Allergy 2011; 66: 637-644.
6. Palikhe NS, Kim SH, Cho BY, Ye YM, Choi GS, Park HS,. Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease. Allergy 2010; 65: 338-346.
7. Szczeklik A, Sanak M,. The broken balance in aspirin hypersensitivity. Eur J Pharmacol 2006; 3: 145-155. (Pubitemid 43340011)
8. Baenkler HW,. Salicylate intolerance: pathophysiology, clinical spectrum, diagnosis and treatment. Dtsch Arztebl Int 2008; 105: 137-142.
9. Dobovisek A, Fajmut A, Brumen M,. Role of expression of prostaglandin synthases 1 and 2 and leukotriene C4 synthase in aspirin-intolerant asthma: a theoretical study. J Pharmacokinet Pharmacodyn 2011; 38: 261-278.
10. Schafer D, Lindenthal U, Wagner M, Bolcskei PL, Baenkler HW,. Effect of prostaglandin E2 on eicosanoid release by human bronchial biopsy specimens from normal and inflamed mucosa. Thorax 1996; 51: 919-923. (Pubitemid 26289032)
11. Schäfer D, Maune S,. Pathogenic Mechanisms and In Vitro Diagnosis of AERD. J Allergy (Cario) 2012; 2012: 18.
12. Lumry WR, Curd JG, Zeiger RS, Pleskow WW, Stevenson DD,. Aspirin sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administration. J Allergy Clin Immunol 1983; 71: 580-587. (Pubitemid 13061623)
13. Gosepath J, Schaefer D, Amedee RG, Mann WJ,. Individual Monitoring of Aspirin Desensitization. Arch Otolaryngol Head Neck Surg 2001; 127: 316-321. (Pubitemid 32205391)
14. Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA,. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol 1996; 98: 751-758. (Pubitemid 26357241)
15. Lee JY, Simon RA, Stevenson DD,. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2007; 119: 157-164. (Pubitemid 46037806)
16. Lanas A, Wu P, Medin J, Mills EJ,. Low Doses of Acetylsalicylic Acid Increase Risk of Gastrointestinal Bleeding in a Meta-Analysis. Clin Gastroenterol Hepatol 2011; 9: 762-768.
17. Moberg C, Naesdal J Jr, Svedberg L-E, Duchateau D, Harte N,. Impact of gastrointestinal problems on adherence to low-dose acetylsalicylic acid: a quantitative study in patients with cardiovascular risk. Patient 2011; 4: 103-113.
18. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. Rhinology 2012; 50: 1-12.
19. Stevenson DD, Sanchez-Borges M, Szczeklik A,. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001; 87: 177-180. (Pubitemid 32879888)
20. Schafer D,. Testing and typing of eicosanoid-patterns. J Physiol Pharmacol 2006; 57 (Suppl 12): 47-64. (Pubitemid 46569828)
21. Schafer D, Schmid M, Gode U, Baenkler H,. Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics. Eur Respir J 1999; 13: 638-646. (Pubitemid 29180179)
22. Lildholdt T, Rundcrantz H, Bende M, Larsen K,. Glucocorticoid treatment for nasal polyps: the use of topical budesonide powder, intramuscular betamethasone, and surgical treatment. Arch Otolaryngol Head Neck Surg 1997; 123: 595-600. (Pubitemid 27258448)
23. Malm L,. Assessment and staging of nasal polyposis. Acta Otolaryngol 1997; 117: 465-467. (Pubitemid 27359751)
24. Wolfensberger M, Schnieper I,. Sniffin' Sticks: a new system for olfactory assessment in routine clinical practice. HNO 1999; 47: 629-636. (Pubitemid 29361655)
25. Maune S, Rudert H, Heissenberg MC, Schmidt C, Eggers S, Landmann K, et al. Concepts for measuring quality of life in patients with chronic sinusitis. Laryngorhinootologie 1999; 78: 475-480. (Pubitemid 29470290)
26. Lund VJ, Kennedy DW,. Quantification for staging sinusitis. The Staging and Therapy Group. Ann Otol Rhinol Laryngol Suppl 1995; 167: 17-21.
27. Lund VJ, Kennedy DW,. Staging for rhinosinusitis. Otolaryngol Head Neck Surg 1997; 2: 35-40.
28. Baker TW, Quinn JM,. Aspirin therapy in aspirin-exacerbated respiratory disease: A risk-benefit analysis for the practicing allergist. Allergy Asthma Proc 2011; 32: 335-340.
29. Rozsasi A, Polzehl D, Deutschle T, Smith E, Wiesmiller K, Riechelmann H, et al. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily. Allergy 2008; 63: 1228-1234.